Skip to content
logo with text
  • What we do
    • Scouting and Out-Licensing
    • Consulting to BD&L
    • Training
  • Current Projects
    • Topical Candidate for Eczema and Related Conditions
    • Custom Nanocomplex Formulation Opportunities
  • About Us
  • Contact
Menu
  • What we do
    • Scouting and Out-Licensing
    • Consulting to BD&L
    • Training
  • Current Projects
    • Topical Candidate for Eczema and Related Conditions
    • Custom Nanocomplex Formulation Opportunities
  • About Us
  • Contact

Annual Review 2022 & 2023 Predictions

  • Post author:Carlos
  • Post published:December 15, 2022
  • Post category:Uncategorized
  • Post comments:0 Comments

https://youtu.be/69azx95XaGQ Here is our annual year in review, along with some predictions (which are rarely correct) for 2023.

Continue ReadingAnnual Review 2022 & 2023 Predictions
Read more about the article Scouting Lessons Learned

Scouting Lessons Learned

  • Post author:Carlos
  • Post published:December 2, 2022
  • Post category:Business Development/Licensing
  • Post comments:0 Comments

https://youtu.be/nXkNQpLNz-M We recently completed a Scouting project on behalf of a geographically-focused company. In this video, we discuss some of the lessons learned. We also provide some suggestions for addressing…

Continue ReadingScouting Lessons Learned
Read more about the article Partnering in 2022: What’s New?

Partnering in 2022: What’s New?

  • Post author:Carlos
  • Post published:June 10, 2022
  • Post category:Business Development/Licensing/Conferences
  • Post comments:0 Comments

Still working on that wave? Like many of you, I am also knee-deep in last minute preparations for BIO. For many of us, this will be the first live partnering…

Continue ReadingPartnering in 2022: What’s New?
Read more about the article Is Licensing A Waste of Time?

Is Licensing A Waste of Time?

  • Post author:Carlos
  • Post published:March 28, 2022
  • Post category:Business Development/Licensing
  • Post comments:0 Comments

Easier said than done... Consider the following scenario… You are the CEO of an emerging biotech company. You have managed to raise enough capital to advance a small molecule through…

Continue ReadingIs Licensing A Waste of Time?
Read more about the article The Future of Partnering Conferences

The Future of Partnering Conferences

  • Post author:Carlos
  • Post published:June 30, 2021
  • Post category:Conferences/COVID-19
  • Post comments:3 Comments

Sign of the times... Passport in date? Check Suits still fit? Too big, but wearable. Negative COVID tests? Yes! Three in hand. Fully Vaccinated? Yes, since April. Masks? Plenty. But…

Continue ReadingThe Future of Partnering Conferences
Read more about the article Clusters Revisited

Clusters Revisited

  • Post author:Carlos
  • Post published:February 5, 2021
  • Post category:Business Development/Licensing/Conferences/Government
  • Post comments:0 Comments

…the enduring competitive advantages in a global economy lie increasingly in local things – knowledge, relationships, motivation – that distant rivals cannot match.  When Michael Porter wrote this in 1998,…

Continue ReadingClusters Revisited
Read more about the article The Coronavirus Vaccine Scam

The Coronavirus Vaccine Scam

  • Post author:Carlos
  • Post published:December 1, 2020
  • Post category:COVID-19/Drug Development/Social Media
  • Post comments:0 Comments

Of course we are being facetious when we use the word “scam.”But it nevertheless reflects the opinion of a major portion of the US population that have, shall we say,…

Continue ReadingThe Coronavirus Vaccine Scam
Read more about the article Have we seen this before?
Is this 2020?

Have we seen this before?

  • Post author:Carlos
  • Post published:September 29, 2020
  • Post category:COVID-19/Uncategorized
  • Post comments:0 Comments

Is this 2020?Consider the following scenario…It is the beginning of the calendar year.A heretofore new and unknown virus is circulating the globe, causing significant morbidity and mortality.Half-way through the year,…

Continue ReadingHave we seen this before?
Read more about the article Virtual Partnering Survey Results

Virtual Partnering Survey Results

  • Post author:Carlos
  • Post published:May 11, 2020
  • Post category:Conferences
  • Post comments:0 Comments

Many thanks to every one who participated in our recent survey on virtual / digital partnering.  On the day this survey launched, the US had ~394,000 cases of COVID-19, with…

Continue ReadingVirtual Partnering Survey Results
Read more about the article A Post-COVID-19 World

A Post-COVID-19 World

  • Post author:Carlos
  • Post published:April 13, 2020
  • Post category:Conferences/Drug Development/Due Diligence/Pharmaceutical
  • Post comments:0 Comments

What will our industry and economy look like in the post-COVID-19 era?First of all, we would never recommend paying too much attention to anyone who knows precisely what the answer…

Continue ReadingA Post-COVID-19 World
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 34
  • Go to the next page

Recent Posts

  • Widening the Funnel
  • Widening the Funnel
  • The Coming Preclinical Licensing Bottleneck
  • The “Reach Through”: When Your Sublicensees Success Becomes Your Headache
  • The Three Faces of AI: Claude Models and BD

Archives

  • September 2026
  • May 2026
  • March 2026
  • February 2026
  • January 2026
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • June 2025
  • December 2024
  • October 2024
  • September 2024
  • April 2024
  • May 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • June 2022
  • March 2022
  • June 2021
  • February 2021
  • December 2020
  • September 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • July 2019
  • June 2019
  • May 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • May 2014
  • April 2014
  • February 2014
  • January 2014
  • November 2013
  • October 2013
  • September 2013
  • August 2013
  • July 2013
  • June 2013
  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010

Categories

  • Artificial Intelligence
  • BD&L
  • Biosimilars
  • Biotech
  • Business Development/Licensing
  • China
  • Conferences
  • COVID-19
  • CRO
  • Diagnostics
  • Digital Health
  • Digital Medicine
  • Downsizing
  • Drug Delivery
  • Drug Development
  • Drug Discovery
  • Due Diligence
  • Emerging Markets
  • Entrepreneurship
  • Europe
  • Financing
  • Generics
  • Government
  • India
  • Marketing
  • Mergers & Acquisitions
  • Offshoring
  • Outsourcing
  • Pharmaceutical
  • Planning
  • Pricing
  • Reimbursement
  • Social Media
  • Tech Transfer
  • Uncategorized
  • Venture Capital

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Get in touch

To contact us, please email us at mail: info@lacertabio.com to schedule your free consultation, or call tele:+1 (845) 293-3343.